X0303 4/A 2009-10-16 2009-10-20 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001163156 ALTA BIOPHARMA PARTNERS II LP ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001163189 ALTA BIOPHARMA MANAGEMENT II LLC ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001163157 ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001276361 ALTA PARTNERS II INC ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001198323 DELEAGE JEAN ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001198321 CHAMPSI FARAH ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94132 0 0 1 0 Common Stock 2009-10-16 4 P 0 337245 1.38 A 5484063 D Common Stock 2009-10-16 4 P 0 12406 1.38 A 180204 I By Side Fund Warrants (right to buy) 1.66 2009-10-16 4 P 0 118036 0.125 A 2009-10-16 2012-10-16 Common Stock 118036 640996 D Warrants (right to buy) 1.66 2009-10-16 4 P 0 4342 0.125 A 2009-10-16 2012-10-16 Common Stock 4342 10949 I By Side Fund Acquired from the Issuer pursuant to the Securities Purchase Agreement dated October 12, 2009. This price is the result of $1.43 per share, pursuant to Securities Purchase Agreement dated October 12, 2009, less the cost of warrants. These securities are held of record by Alta BioPharma Partners II, L.P. ("ABPII"). Alta BioPharma Management II, LLC ("ABMII") is the General Partner of ABPII. Jean Deleage and Farah Champsi are managing directors and Edward Penhoet is a director of ABMII and they exercise shared voting and investment power with respect to the shares owned by ABPII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extend of his or her proportionate pecuniary interest therein. Mr. Edward Penhoet is a director of the Issuer and files separate reports pursuant to Section 16 of the Securities Exchange Act of 1934, as amended. These securities are held of record by Alta Embarcadero BioPharma Partners II, LLC ("AEBPII"). Alta Partners II, Inc. ("APII") provides investment advisory services to ABPII and AEBPII. Jean Deleage and Farah Champsi are managers of AEBPII and exercise shared voting and investment power over the shares held by AEBPII. Each of the reporting persons disclaims beneficial ownership of all such shares except to the extend of his or her proportionate pecuniary interest therein. This form 4 is amended to correct the warrants purchased by Alta Embarcadero BioPharma Partners II, LLC listed under table II column 7. By Alta BioPharma Management II, LLC, /s/ Jean Deleage, Managing Director 2009-10-20 /s/ Jean Deleage, Managing Director 2009-10-20 /s/ Jean Deleage, Manager 2009-10-20 /s/ Jean Deleage, President 2009-10-20 /s/ Jean Deleage 2009-10-20 /s/ Farah Champsi 2009-10-20